Pain Goodbye Medicated Cream
NDC Package 15667-5049-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Pain Goodbye Medicated Cream is a medication used as Menthol    External Analgesic. Marketed by Austin Biotechnology Inc, this product is identified by NDC 15667-5049 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
15667-5049-4
Package Description
280 g in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
15667504904
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Pain Goodbye Medicated Cream
Dosage Form
-
Usage Information
This product is used as Menthol    External Analgesic. Uses for the temporary relief of minor aches, and points of muscles and joints associated with simple backache, arthritis and strains.

Regulatory & Marketing

Labeler Name
Austin Biotechnology Inc
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
10-26-2011
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 15667-5049-4 identifies a specific commercial package of 280 g in 1 bottle, plastic of Pain Goodbye Medicated Cream, labeled by Austin Biotechnology Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Austin Biotechnology Inc on October 26, 2011. The current certification is valid through December 31, 2017.

How is this Austin Biotechnology Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 15667504904. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
15667-5049-4
11-Digit CMS (5-4-2)
15667-5049-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.